LGX-818
-
- Product NameLGX-818
- CAS No.1269440-17-6
- Purity98%
- Min Quantity
- Price300~3900
- View Contact Detail
Detailed Description
Encorafenib, also known as LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis and was disclosed at the spring 2013 American Chemical Society meeting in New Orleans.